▶ 調査レポート

世界の医薬品安全性ソリューション・ファーマコビジランス市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Drug Safety Solutions and Pharmacovigilance Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の医薬品安全性ソリューション・ファーマコビジランス市場 2021:企業別、地域別、種類・用途別 / Global Drug Safety Solutions and Pharmacovigilance Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12234資料のイメージです。• レポートコード:GIR-107A12234
• 出版社/出版日:GlobalInfoResearch / 2021年7月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、122ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、医薬品安全性ソリューション・ファーマコビジランスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。医薬品安全性ソリューション・ファーマコビジランスの種類別市場規模(一般フォーム、カスタマイズフォーム)、用途別市場規模(バイオテクノロジー・医薬品、委託研究機関(CROS)、病院、KPO/BPO、医療機関、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・医薬品安全性ソリューション・ファーマコビジランスの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pharmaceutical Product Development, LLC、Drug Safety Solutions Limited、C3i、Worldwide Clinical Trials、Bioclinica、United Biosource LLC、Ennov、AB Cube、Covance Inc.、Accenture、PRA Health Sciences, Inc.、Ergomed、IQVIA、Genpact、Cognizant、Parexel International Corporation、ArisGlobal、ICON plc、Oracle、Syneos Health
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:一般フォーム、カスタマイズフォーム
・用途別分析2016年-2026年:バイオテクノロジー・医薬品、委託研究機関(CROS)、病院、KPO/BPO、医療機関、その他
・医薬品安全性ソリューション・ファーマコビジランスの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・医薬品安全性ソリューション・ファーマコビジランスのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・医薬品安全性ソリューション・ファーマコビジランスのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・医薬品安全性ソリューション・ファーマコビジランスの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・医薬品安全性ソリューション・ファーマコビジランスの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drug Safety Solutions and Pharmacovigilance market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Drug Safety Solutions and Pharmacovigilance size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Drug Safety Solutions and Pharmacovigilance market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Drug Safety Solutions and Pharmacovigilance market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Standard Form
Customized Form

Market segment by Application, can be divided into
Biotechnology and Pharmaceuticals
Contract Research Organization (CROS)
Hospital
KPO / BPO
Healthcare Institutions
Others

Market segment by players, this report covers
Pharmaceutical Product Development, LLC
Drug Safety Solutions Limited
C3i
Worldwide Clinical Trials
Bioclinica
United Biosource LLC
Ennov
AB Cube
Covance Inc.
Accenture
PRA Health Sciences, Inc.
Ergomed
IQVIA
Genpact
Cognizant
Parexel International Corporation
ArisGlobal
ICON plc
Oracle
Syneos Health

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Drug Safety Solutions and Pharmacovigilance
1.2 Classification of Drug Safety Solutions and Pharmacovigilance by Type
1.2.1 Overview: Global Drug Safety Solutions and Pharmacovigilance Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type in 2020
1.2.3 Standard Form
1.2.4 Customized Form
1.3 Global Drug Safety Solutions and Pharmacovigilance Market by Application
1.3.1 Overview: Global Drug Safety Solutions and Pharmacovigilance Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Biotechnology and Pharmaceuticals
1.3.3 Contract Research Organization (CROS)
1.3.4 Hospital
1.3.5 KPO / BPO
1.3.6 Healthcare Institutions
1.3.7 Others
1.4 Global Drug Safety Solutions and Pharmacovigilance Market Size & Forecast
1.5 Global Drug Safety Solutions and Pharmacovigilance Market Size and Forecast by Region
1.5.1 Global Drug Safety Solutions and Pharmacovigilance Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Drug Safety Solutions and Pharmacovigilance Market Size by Region, (2016-2021)
1.5.3 North America Drug Safety Solutions and Pharmacovigilance Market Size and Prospect (2016-2026)
1.5.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size and Prospect (2016-2026)
1.5.6 South America Drug Safety Solutions and Pharmacovigilance Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Drug Safety Solutions and Pharmacovigilance Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Safety Solutions and Pharmacovigilance Market Drivers
1.6.2 Drug Safety Solutions and Pharmacovigilance Market Restraints
1.6.3 Drug Safety Solutions and Pharmacovigilance Trends Analysis
2 Company Profiles
2.1 Pharmaceutical Product Development, LLC
2.1.1 Pharmaceutical Product Development, LLC Details
2.1.2 Pharmaceutical Product Development, LLC Major Business
2.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.1.4 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Pharmaceutical Product Development, LLC Recent Developments and Future Plans
2.2 Drug Safety Solutions Limited
2.2.1 Drug Safety Solutions Limited Details
2.2.2 Drug Safety Solutions Limited Major Business
2.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.2.4 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Drug Safety Solutions Limited Recent Developments and Future Plans
2.3 C3i
2.3.1 C3i Details
2.3.2 C3i Major Business
2.3.3 C3i Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.3.4 C3i Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 C3i Recent Developments and Future Plans
2.4 Worldwide Clinical Trials
2.4.1 Worldwide Clinical Trials Details
2.4.2 Worldwide Clinical Trials Major Business
2.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.4.4 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Worldwide Clinical Trials Recent Developments and Future Plans
2.5 Bioclinica
2.5.1 Bioclinica Details
2.5.2 Bioclinica Major Business
2.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.5.4 Bioclinica Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Bioclinica Recent Developments and Future Plans
2.6 United Biosource LLC
2.6.1 United Biosource LLC Details
2.6.2 United Biosource LLC Major Business
2.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.6.4 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 United Biosource LLC Recent Developments and Future Plans
2.7 Ennov
2.7.1 Ennov Details
2.7.2 Ennov Major Business
2.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.7.4 Ennov Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Ennov Recent Developments and Future Plans
2.8 AB Cube
2.8.1 AB Cube Details
2.8.2 AB Cube Major Business
2.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.8.4 AB Cube Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 AB Cube Recent Developments and Future Plans
2.9 Covance Inc.
2.9.1 Covance Inc. Details
2.9.2 Covance Inc. Major Business
2.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.9.4 Covance Inc. Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Covance Inc. Recent Developments and Future Plans
2.10 Accenture
2.10.1 Accenture Details
2.10.2 Accenture Major Business
2.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.10.4 Accenture Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Accenture Recent Developments and Future Plans
2.11 PRA Health Sciences, Inc.
2.11.1 PRA Health Sciences, Inc. Details
2.11.2 PRA Health Sciences, Inc. Major Business
2.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.11.4 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 PRA Health Sciences, Inc. Recent Developments and Future Plans
2.12 Ergomed
2.12.1 Ergomed Details
2.12.2 Ergomed Major Business
2.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.12.4 Ergomed Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Ergomed Recent Developments and Future Plans
2.13 IQVIA
2.13.1 IQVIA Details
2.13.2 IQVIA Major Business
2.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.13.4 IQVIA Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 IQVIA Recent Developments and Future Plans
2.14 Genpact
2.14.1 Genpact Details
2.14.2 Genpact Major Business
2.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.14.4 Genpact Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.14.5 Genpact Recent Developments and Future Plans
2.15 Cognizant
2.15.1 Cognizant Details
2.15.2 Cognizant Major Business
2.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.15.4 Cognizant Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.15.5 Cognizant Recent Developments and Future Plans
2.16 Parexel International Corporation
2.16.1 Parexel International Corporation Details
2.16.2 Parexel International Corporation Major Business
2.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.16.4 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.16.5 Parexel International Corporation Recent Developments and Future Plans
2.17 ArisGlobal
2.17.1 ArisGlobal Details
2.17.2 ArisGlobal Major Business
2.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.17.4 ArisGlobal Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.17.5 ArisGlobal Recent Developments and Future Plans
2.18 ICON plc
2.18.1 ICON plc Details
2.18.2 ICON plc Major Business
2.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.18.4 ICON plc Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.18.5 ICON plc Recent Developments and Future Plans
2.19 Oracle
2.19.1 Oracle Details
2.19.2 Oracle Major Business
2.19.3 Oracle Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.19.4 Oracle Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.19.5 Oracle Recent Developments and Future Plans
2.20 Syneos Health
2.20.1 Syneos Health Details
2.20.2 Syneos Health Major Business
2.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Product and Solutions
2.20.4 Syneos Health Drug Safety Solutions and Pharmacovigilance Revenue, Gross Margin and Market Share (2019-2021)
2.20.5 Syneos Health Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Drug Safety Solutions and Pharmacovigilance Players Market Share
3.2.2 Top 10 Drug Safety Solutions and Pharmacovigilance Players Market Share
3.2.3 Market Competition Trend
3.3 Drug Safety Solutions and Pharmacovigilance Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Drug Safety Solutions and Pharmacovigilance Revenue and Market Share by Type (2016-2021)
4.2 Global Drug Safety Solutions and Pharmacovigilance Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2016-2021)
5.2 Drug Safety Solutions and Pharmacovigilance Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2026)
6.2 North America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2026)
6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country
6.3.1 North America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2026)
6.3.2 United States Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
6.3.3 Canada Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
6.3.4 Mexico Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2026)
7.2 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2026)
7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country
7.3.1 Europe Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2026)
7.3.2 Germany Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
7.3.3 France Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
7.3.5 Russia Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
7.3.6 Italy Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2026)
8.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2026)
8.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region
8.3.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Region (2016-2026)
8.3.2 China Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8.3.3 Japan Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8.3.4 South Korea Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8.3.5 India Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
8.3.7 Australia Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2026)
9.2 South America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2026)
9.3 South America Drug Safety Solutions and Pharmacovigilance Market Size by Country
9.3.1 South America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2026)
9.3.2 Brazil Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
9.3.3 Argentina Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2026)
10.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2026)
10.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country
10.3.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2026)
10.3.2 Turkey Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
10.3.4 UAE Drug Safety Solutions and Pharmacovigilance Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Drug Safety Solutions and Pharmacovigilance Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Drug Safety Solutions and Pharmacovigilance Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Drug Safety Solutions and Pharmacovigilance Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) by Region (2016-2021)
Table 5. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Region (2021-2026)
Table 6. Pharmaceutical Product Development, LLC Corporate Information, Head Office, and Major Competitors
Table 7. Pharmaceutical Product Development, LLC Major Business
Table 8. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 9. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Drug Safety Solutions Limited Corporate Information, Head Office, and Major Competitors
Table 11. Drug Safety Solutions Limited Major Business
Table 12. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 13. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. C3i Corporate Information, Head Office, and Major Competitors
Table 15. C3i Major Business
Table 16. C3i Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 17. C3i Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Worldwide Clinical Trials Corporate Information, Head Office, and Major Competitors
Table 19. Worldwide Clinical Trials Major Business
Table 20. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 21. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Bioclinica Corporate Information, Head Office, and Major Competitors
Table 23. Bioclinica Major Business
Table 24. Bioclinica Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 25. Bioclinica Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. United Biosource LLC Corporate Information, Head Office, and Major Competitors
Table 27. United Biosource LLC Major Business
Table 28. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 29. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Ennov Corporate Information, Head Office, and Major Competitors
Table 31. Ennov Major Business
Table 32. Ennov Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 33. Ennov Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. AB Cube Corporate Information, Head Office, and Major Competitors
Table 35. AB Cube Major Business
Table 36. AB Cube Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 37. AB Cube Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Covance Inc. Corporate Information, Head Office, and Major Competitors
Table 39. Covance Inc. Major Business
Table 40. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 41. Covance Inc. Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Accenture Corporate Information, Head Office, and Major Competitors
Table 43. Accenture Major Business
Table 44. Accenture Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 45. Accenture Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. PRA Health Sciences, Inc. Corporate Information, Head Office, and Major Competitors
Table 47. PRA Health Sciences, Inc. Major Business
Table 48. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 49. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Ergomed Corporate Information, Head Office, and Major Competitors
Table 51. Ergomed Major Business
Table 52. Ergomed Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 53. Ergomed Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. IQVIA Corporate Information, Head Office, and Major Competitors
Table 55. IQVIA Major Business
Table 56. IQVIA Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 57. IQVIA Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Genpact Corporate Information, Head Office, and Major Competitors
Table 59. Genpact Major Business
Table 60. Genpact Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 61. Genpact Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 62. Cognizant Corporate Information, Head Office, and Major Competitors
Table 63. Cognizant Major Business
Table 64. Cognizant Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 65. Cognizant Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 66. Parexel International Corporation Corporate Information, Head Office, and Major Competitors
Table 67. Parexel International Corporation Major Business
Table 68. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 69. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 70. ArisGlobal Corporate Information, Head Office, and Major Competitors
Table 71. ArisGlobal Major Business
Table 72. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 73. ArisGlobal Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 74. ICON plc Corporate Information, Head Office, and Major Competitors
Table 75. ICON plc Major Business
Table 76. ICON plc Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 77. ICON plc Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 78. Oracle Corporate Information, Head Office, and Major Competitors
Table 79. Oracle Major Business
Table 80. Oracle Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 81. Oracle Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 82. Syneos Health Corporate Information, Head Office, and Major Competitors
Table 83. Syneos Health Major Business
Table 84. Syneos Health Drug Safety Solutions and Pharmacovigilance Product and Solutions
Table 85. Syneos Health Drug Safety Solutions and Pharmacovigilance Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 86. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) by Players (2019-2021)
Table 87. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players (2019-2021)
Table 88. Breakdown of Drug Safety Solutions and Pharmacovigilance by Company Type (Tier 1, Tier 2 and Tier 3)
Table 89. Drug Safety Solutions and Pharmacovigilance Players Head Office, Products and Services Provided
Table 90. Drug Safety Solutions and Pharmacovigilance Mergers & Acquisitions in the Past Five Years
Table 91. Drug Safety Solutions and Pharmacovigilance New Entrants and Expansion Plans
Table 92. Global Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) by Type (2016-2021)
Table 93. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Type (2016-2021)
Table 94. Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Type (2021-2026)
Table 95. Global Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021)
Table 96. Global Drug Safety Solutions and Pharmacovigilance Revenue Forecast by Application (2021-2026)
Table 97. North America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2021) & (USD Million)
Table 98. North America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2021-2026) & (USD Million)
Table 99. North America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021) & (USD Million)
Table 100. North America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2021-2026) & (USD Million)
Table 101. North America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2021) & (USD Million)
Table 102. North America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2021-2026) & (USD Million)
Table 103. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2021) & (USD Million)
Table 104. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Type (2021-2026) & (USD Million)
Table 105. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021) & (USD Million)
Table 106. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Application (2021-2026) & (USD Million)
Table 107. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2021) & (USD Million)
Table 108. Europe Drug Safety Solutions and Pharmacovigilance Revenue by Country (2021-2026) & (USD Million)
Table 109. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2021) & (USD Million)
Table 110. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Type (2021-2026) & (USD Million)
Table 111. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021) & (USD Million)
Table 112. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Application (2021-2026) & (USD Million)
Table 113. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Region (2016-2021) & (USD Million)
Table 114. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue by Region (2021-2026) & (USD Million)
Table 115. South America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2021) & (USD Million)
Table 116. South America Drug Safety Solutions and Pharmacovigilance Revenue by Type (2021-2026) & (USD Million)
Table 117. South America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021) & (USD Million)
Table 118. South America Drug Safety Solutions and Pharmacovigilance Revenue by Application (2021-2026) & (USD Million)
Table 119. South America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2021) & (USD Million)
Table 120. South America Drug Safety Solutions and Pharmacovigilance Revenue by Country (2021-2026) & (USD Million)
Table 121. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Type (2016-2021) & (USD Million)
Table 122. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Type (2021-2026) & (USD Million)
Table 123. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Application (2016-2021) & (USD Million)
Table 124. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Application (2021-2026) & (USD Million)
Table 125. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Country (2016-2021) & (USD Million)
Table 126. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Drug Safety Solutions and Pharmacovigilance Picture
Figure 2. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type in 2020
Figure 3. Standard Form
Figure 4. Customized Form
Figure 5. Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application in 2020
Figure 6. Biotechnology and Pharmaceuticals Picture
Figure 7. Contract Research Organization (CROS) Picture
Figure 8. Hospital Picture
Figure 9. KPO / BPO Picture
Figure 10. Healthcare Institutions Picture
Figure 11. Others Picture
Figure 12. Global Drug Safety Solutions and Pharmacovigilance Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Drug Safety Solutions and Pharmacovigilance Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Region (2016-2026)
Figure 15. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Region in 2020
Figure 16. North America Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Drug Safety Solutions and Pharmacovigilance Market Drivers
Figure 22. Drug Safety Solutions and Pharmacovigilance Market Restraints
Figure 23. Drug Safety Solutions and Pharmacovigilance Market Trends
Figure 24. Pharmaceutical Product Development, LLC Recent Developments and Future Plans
Figure 25. Drug Safety Solutions Limited Recent Developments and Future Plans
Figure 26. C3i Recent Developments and Future Plans
Figure 27. Worldwide Clinical Trials Recent Developments and Future Plans
Figure 28. Bioclinica Recent Developments and Future Plans
Figure 29. United Biosource LLC Recent Developments and Future Plans
Figure 30. Ennov Recent Developments and Future Plans
Figure 31. AB Cube Recent Developments and Future Plans
Figure 32. Covance Inc. Recent Developments and Future Plans
Figure 33. Accenture Recent Developments and Future Plans
Figure 34. PRA Health Sciences, Inc. Recent Developments and Future Plans
Figure 35. Ergomed Recent Developments and Future Plans
Figure 36. IQVIA Recent Developments and Future Plans
Figure 37. Genpact Recent Developments and Future Plans
Figure 38. Cognizant Recent Developments and Future Plans
Figure 39. Parexel International Corporation Recent Developments and Future Plans
Figure 40. ArisGlobal Recent Developments and Future Plans
Figure 41. ICON plc Recent Developments and Future Plans
Figure 42. Oracle Recent Developments and Future Plans
Figure 43. Syneos Health Recent Developments and Future Plans
Figure 44. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Players in 2020
Figure 45. Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 46. Global Top 3 Players Drug Safety Solutions and Pharmacovigilance Revenue Market Share in 2020
Figure 47. Global Top 10 Players Drug Safety Solutions and Pharmacovigilance Revenue Market Share in 2020
Figure 48. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 49. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Type in 2020
Figure 50. Global Drug Safety Solutions and Pharmacovigilance Market Share Forecast by Type (2021-2026)
Figure 51. Global Drug Safety Solutions and Pharmacovigilance Revenue Share by Application in 2020
Figure 52. Global Drug Safety Solutions and Pharmacovigilance Market Share Forecast by Application (2021-2026)
Figure 53. North America Drug Safety Solutions and Pharmacovigilance Sales Market Share by Type (2016-2026)
Figure 54. North America Drug Safety Solutions and Pharmacovigilance Sales Market Share by Application (2016-2026)
Figure 55. North America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Country (2016-2026)
Figure 56. United States Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Canada Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Mexico Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Europe Drug Safety Solutions and Pharmacovigilance Sales Market Share by Type (2016-2026)
Figure 60. Europe Drug Safety Solutions and Pharmacovigilance Sales Market Share by Application (2016-2026)
Figure 61. Europe Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Country (2016-2026)
Figure 62. Germany Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. France Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. United Kingdom Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Russia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. Italy Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Sales Market Share by Type (2016-2026)
Figure 68. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Sales Market Share by Application (2016-2026)
Figure 69. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Region (2016-2026)
Figure 70. China Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Japan Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. South Korea Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. India Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Southeast Asia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Australia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South America Drug Safety Solutions and Pharmacovigilance Sales Market Share by Type (2016-2026)
Figure 77. South America Drug Safety Solutions and Pharmacovigilance Sales Market Share by Application (2016-2026)
Figure 78. South America Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Country (2016-2026)
Figure 79. Brazil Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Argentina Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 81. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Sales Market Share by Type (2016-2026)
Figure 82. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Sales Market Share by Application (2016-2026)
Figure 83. Middle East and Africa Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Country (2016-2026)
Figure 84. Turkey Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 85. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 86. UAE Drug Safety Solutions and Pharmacovigilance Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 87. Methodology
Figure 88. Research Process and Data Source